FDA MAMMOGRAPHY QUALITY STANDARDS INTERIM REG
This article was originally published in The Gray Sheet
Executive SummaryFDA MAMMOGRAPHY QUALITY STANDARDS INTERIM REG seeks advice on standards that should be established for mammography of patients with breast implants. Published in the Dec. 21 Federal Register, the interim final reg explains that "FDA does not believe that sufficient information is presently available with regard to special requirements for mammography of patients with breast implants." The agency asks for "comments on standards for consideration in development of the final rule."
You may also be interested in...
Biogen’s “recipe-driven qualification” knowledge management program standardizes data collection and reporting in the laboratory, with efficiency gains of 66%.
Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Landmark studies of newer techniques have led the American Urological Association to update its guidelines.